If You've Been Diagnosed with Melanoma and are Considering Sentinel Lymph Node Biopsy Surgery (SLNB), Genomic Testing May be Right for You

For many patients eligible for the sentinel lymph node biopsy procedure,
DecisionDx®-Melanoma can provide important information to consider before deciding to proceed with the surgery.

The DecisionDx-Melanoma test looks at the biology of your individual tumor to predict how aggressive your melanoma may be, to help determine the risk of your cancer recurring and the likelihood of having a positive sentinel lymph node.

DecisionDx®-Melanoma More Accurately Predicts the Risk of Your Individual Melanoma Recurring or Spreading

Genomic testing with DecisionDx-Melanoma provides personalized information about your individual risk level, including the likelihood of sentinel lymph node positivity, so you and your healthcare professional can determine which treatment and monitoring plans are right for you.


DecisionDx-Melanoma Testing Process is Simple

The DecisionDx-Melanoma test is performed on existing tissue taken from your original biopsy or surgery, so there is no need for another procedure. Your healthcare professional can order the test for you.

DecisionDx-Melanoma is covered by many insurance plans including Medicare and the VA.

What's Next?

Is DecisionDx-Melanoma Right for You?

Download a discussion guide to help you and your healthcare professional discuss and decide if personalized genomic information from DecisionDx-Melanoma is right for you.

How Do You Use the Test Results?